Takuro Uchida

1.2k total citations
38 papers, 448 citations indexed

About

Takuro Uchida is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Takuro Uchida has authored 38 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Epidemiology, 31 papers in Hepatology and 8 papers in Infectious Diseases. Recurrent topics in Takuro Uchida's work include Hepatitis C virus research (27 papers), Hepatitis B Virus Studies (25 papers) and Liver Disease Diagnosis and Treatment (19 papers). Takuro Uchida is often cited by papers focused on Hepatitis C virus research (27 papers), Hepatitis B Virus Studies (25 papers) and Liver Disease Diagnosis and Treatment (19 papers). Takuro Uchida collaborates with scholars based in Japan, United States and Australia. Takuro Uchida's co-authors include Kazuaki Chayama, Michio Imamura, C. Nelson Hayes, Masataka Tsuge, Hiroshi Aikata, Daiki Miki, Nobuhiko Hiraga, Hidenori Ochi, Hiromi Kan and Hiromi Abe‐Chayama and has published in prestigious journals such as PLoS ONE, Hepatology and Journal of Virology.

In The Last Decade

Takuro Uchida

36 papers receiving 445 citations

Peers

Countries citing papers authored by Takuro Uchida

Since Specialization

Citations

This map shows the geographic impact of Takuro Uchida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takuro Uchida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takuro Uchida more than expected).

Fields of papers citing papers by Takuro Uchida

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takuro Uchida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takuro Uchida. The network helps show where Takuro Uchida may publish in the future.

Co-authorship network of co-authors of Takuro Uchida

This figure shows the co-authorship network connecting the top 25 collaborators of Takuro Uchida. A scholar is included among the top collaborators of Takuro Uchida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takuro Uchida. Takuro Uchida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Interferon alpha induces a stronger antiviral effect than interferon lambda in HBV/HDV infected humanized mice 2024 ·Virus Research ·(unknown), Takuro Uchida, Masataka Tsuge, Nobuhiko Hiraga, Susan L. Uprichard, Ohad Etzion, Jeffrey S. Glenn, Christopher Koh, Theo Heller, Scott J. Cotler, Shiro Oka, Kazuaki Chayama, Harel Dahari	0
2	Alteration of Gene Expression After Entecavir and Pegylated Interferon Therapy in HBV-Infected Chimeric Mouse Liver 2024 ·Viruses ·Hongmei Bao, (unknown), Masataka Tsuge, Takuro Uchida, Shinsuke Uchikawa, Hatsue Fujino, Atsushi Ono, Eisuke Murakami, Tomokazu Kawaoka, Daiki Miki, C. Nelson Hayes, Shiro Oka	1
3	HBV with precore and basal core promoter mutations exhibits a high replication phenotype and causes ER stress-mediated cell death in humanized liver chimeric mice 2023 ·Hepatology ·Takuro Uchida, Michio Imamura, C. Nelson Hayes, (unknown), (unknown), Kazuki Ohya, Hiroshi Aikata, Hiromi Abe‐Chayama, Yuji Ishida, Chise Tateno, Yuichi Hara, Keisuke Hino, Toru Okamoto, Yoshiharu Matsuura, Hideki Aizaki, Kenjiro Wake, Michinori Kohara, T. Jake Liang, Shiro Oka, Kazuaki Chayama	7
4	Acute liver injury in a non-alcoholic fatty liver disease patient with chloroform exposure: a case report 2023 ·Clinical Journal of Gastroenterology ·(unknown), Takuro Uchida, Masataka Tsuge, Eisuke Murakami, Daiki Miki, Tomokazu Kawaoka, Michio Imamura, Hiroshi Aikata, Koji Arihiro, Shiro Oka	2
5	A dual conditional CRISPR-Cas9 system to activate gene editing and reduce off-target effects in human stem cells 2022 ·Molecular Therapy — Nucleic Acids ·(unknown), Takuro Uchida, (unknown), Zongyi Hu, (unknown), (unknown), (unknown), So Gun Hong, T. Jake Liang	14
6	A novel cDNA‐uPA/SCID/Rag2^−/−/Jak3^−/− mouse model for hepatitis virus infection and reconstruction of human immune system 2022 ·Journal of Viral Hepatitis ·Takuro Uchida, (unknown), Michio Imamura, Hiromi Abe‐Chayama, Grace Naswa Makokha, C. Nelson Hayes, Hiroshi Aikata, (unknown), Yuji Ishida, Chise Tateno, (unknown), (unknown), Yuka Tanaka, Hideki Ohdan, Seiji Okada, Kazuaki Chayama	1
7	Promoting mechanism of serum amyloid a family expression in mouse intestinal epithelial cells 2022 ·PLoS ONE ·(unknown), Ryohei Hayashi, Yoshitaka Ueno, (unknown), (unknown), Takuro Uchida, Hidehiko Takigawa, Ryo Yuge, Yuji Urabe, Shiro Oka, Yasuhiko Kitadai, Shinji Tanaka	5
8	Genetically edited hepatic cells expressing the NTCP-S267F variant are resistant to hepatitis B virus infection 2021 ·Molecular Therapy — Methods & Clinical Development ·Takuro Uchida, (unknown), Tadashi Inuzuka, Min Zhang, Joselyn Natasha Allen, Kazuaki Chayama, T. Jake Liang	10
9	Regulation of the Hepatitis B virus replication and gene expression by the multi-functional protein TARDBP 2019 ·Scientific Reports ·Grace Naswa Makokha, Hiromi Abe‐Chayama, (unknown), C. Nelson Hayes, Masataka Tsuge, Tadahiko Yoshima, Yuji Ishida, Yizhou Zhang, Takuro Uchida, Chise Tateno, (unknown), Kazuaki Chayama	17
10	Comparison of intracellular responses between HBV genotype A and C infection in human hepatocyte chimeric mice 2019 ·Journal of Gastroenterology ·(unknown), Masataka Tsuge, Nobuhiko Hiraga, Takuro Uchida, Eisuke Murakami, Grace Naswa Makokha, (unknown), (unknown), (unknown), Hatsue Fujino, Atsushi Ono, Takashi Nakahara, Masami Yamauchi, Hiromi Abe‐Chayama, Tomokazu Kawaoka, Daiki Miki, Michio Imamura, Hiroshi Aikata, C. Nelson Hayes, Kazuaki Chayama	7
11	Real-world efficacy of glecaprevir plus pibrentasvir for chronic hepatitis C patient with previous direct-acting antiviral therapy failures 2018 ·Journal of Gastroenterology ·(unknown), (unknown), Michio Imamura, (unknown), Takuro Uchida, Kei Morio, Hatsue Fujino, Takashi Nakahara, Atsushi Ono, Eisuke Murakami, Tomokazu Kawaoka, Daiki Miki, Masataka Tsuge, Akira Hiramatsu, Hiroshi Aikata, C. Nelson Hayes, Kazuaki Chayama	33
12	Prevalence of NS5A resistance associated variants in NS5A inhibitor treatment failures and an effective treatment for NS5A-P32 deleted hepatitis C virus in humanized mice 2018 ·Biochemical and Biophysical Research Communications ·Yuji Teraoka, Takuro Uchida, Michio Imamura, (unknown), Masataka Tsuge, Hiromi Abe‐Chayama, C. Nelson Hayes, Grace Naswa Makokha, Hiroshi Aikata, Daiki Miki, Hidenori Ochi, Yuji Ishida, Chise Tateno, Kazuaki Chayama	10
13	Evaluation of antiviral effect of type I, II, and III interferons on direct-acting antiviral-resistant hepatitis C virus 2017 ·Antiviral Research ·(unknown), Yuki Takahashi, Takuro Uchida, Makiya Nishikawa, Michio Imamura, Kazuaki Chayama, Yoshinobu Takakura	9
14	Usefulness of humanized cDNA-uPA/SCID mice for the study of hepatitis B virus and hepatitis C virus virology 2017 ·Journal of General Virology ·Takuro Uchida, Michio Imamura, Hiromi Kan, Nobuhiko Hiraga, C. Nelson Hayes, Masataka Tsuge, Hiromi Abe‐Chayama, Hiroshi Aikata, Grace Naswa Makokha, Daiki Miki, Hidenori Ochi, Yuji Ishida, Chise Tateno, Kazuaki Chayama	15
15	Protease Inhibitor Resistance Remains Even After Mutant Strains Become Undetectable by Deep Sequencing 2016 ·The Journal of Infectious Diseases ·Hiromi Kan, Michio Imamura, Takuro Uchida, Nobuhiko Hiraga, C. Nelson Hayes, Masataka Tsuge, Hiromi Abe, Hiroshi Aikata, Grace Naswa Makokha, (unknown), Daiki Miki, Hidenori Ochi, Yuji Ishida, Chise Tateno, Kazuaki Chayama	8
16	Antiviral effects of anti-HBs immunoglobulin and vaccine on HBs antigen seroclearance for chronic hepatitis B infection 2016 ·Journal of Gastroenterology ·Masataka Tsuge, Nobuhiko Hiraga, Takuro Uchida, Hiromi Kan, (unknown), Keiichi Masaki, Atsushi Ono, Takashi Nakahara, Hiromi Abe‐Chayama, Yizhou Zhang, Grace Naswa Makokha, Tomokazu Kawaoka, Daiki Miki, Michio Imamura, Yoshiiku Kawakami, Hiroshi Aikata, Hidenori Ochi, C. Nelson Hayes, Kazuaki Chayama	21
17	Association between variants in the interferon lambda 4 locus and substitutions in the hepatitis C virus non-structural protein 5A 2015 ·Journal of Hepatology ·Sakura Akamatsu, C. Nelson Hayes, Hidenori Ochi, Takuro Uchida, Hiromi Kan, Eisuke Murakami, Hiromi Abe, Masataka Tsuge, Daiki Miki, (unknown), Nobuhiko Hiraga, Michio Imamura, Hiroshi Aikata, Tomokazu Kawaoka, Yoshiiku Kawakami, Kazuaki Chayama	19
18	Rapid, Sensitive, and Accurate Evaluation of Drug Resistant Mutant (NS5A-Y93H) Strain Frequency in Genotype 1b HCV by Invader Assay 2015 ·PLoS ONE ·(unknown), Hidenori Ochi, Eisuke Murakami, Takuro Uchida, Hiromi Kan, Sakura Akamatsu, C. Nelson Hayes, Hiromi Abe, Daiki Miki, Nobuhiko Hiraga, Michio Imamura, Hiroshi Aikata, Kazuaki Chayama	25
19	Elimination of HCV via a non-ISG-mediated mechanism by vaniprevir and BMS-788329 combination therapy in human hepatocyte chimeric mice 2015 ·Virus Research ·Takuro Uchida, Nobuhiko Hiraga, Michio Imamura, (unknown), Hiromi Kan, (unknown), Masataka Tsuge, Hiromi Abe, C. Nelson Hayes, Hiroshi Aikata, Yuji Ishida, Chise Tateno, Joan D. Ellis, Kazuaki Chayama	7
20	Effect of tenofovir disoproxil fumarate on drug-resistant HBV clones 2015 ·Journal of Infection ·Eisuke Murakami, Masataka Tsuge, Nobuhiko Hiraga, Hiromi Kan, Takuro Uchida, Keiichi Masaki, Takashi Nakahara, Atsushi Ono, Daiki Miki, Tomokazu Kawaoka, Hiromi Abe, Michio Imamura, Hiroshi Aikata, Hidenori Ochi, C. Nelson Hayes, Tomoyuki Akita, Junko Tanaka, Kazuaki Chayama	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact